Imprint Wealth’s Eli Lilly LLY Stock Holding History

Imprint Wealth’s Portfolio LLY Stock Details LLY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$109K	Buy	91 +3	+3%	+$3.06K	0.44%	41
2026 Q1	$80.9K	Sell	88 -18	-17%	-$18.2K	0.37%	47
2025 Q4	$114K	Sell	106 -80	-43%	-$76.5K	0.53%	37
2025 Q3	$142K	Buy	+186	New	+$138K	0.45%	46
2024 Q1	$3.25M	Buy	4,276 +2,901	+211%	+$2.06M	0.79%	30
2023 Q4	$808K	Sell	1,375 -1,349	-50%	-$787K	0.65%	46
2023 Q3	$1.46M	Sell	2,724 -835	-23%	-$430K	1.24%	21
2023 Q2	$1.75M	Buy	3,559 +305	+9%	+$128K	1.1%	21
2023 Q1	$1.19M	Buy	+3,254	New	+$1.1M	0.79%	32

Other funds holding LLY

Lilly Endowment Indiananapolis, Indiana $108B AUM 53.87% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

PNC Financial Services Group Pittsburgh, Pennsylvania $202B AUM 37.79% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Imprint Wealth's LLY Position: Q2 2026 in Review

Imprint Wealth increased its Eli Lilly (LLY) stake by 3.4% in Q2 2026, buying an estimated $3.06K and bringing the position to 91 shares worth $109K. The position accounts for 0.44% of the portfolio, ranked #41.

Imprint Wealth first reported a position in LLY in Q1 2023 and has held it in 9 quarters since. The position peaked at $3.25M in Q1 2024. 4,624 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

Imprint Wealth held 91 shares of Eli Lilly worth $109K as of Q2 2026.
Imprint Wealth bought 3 Eli Lilly shares in Q2 2026, an estimated $3.06K.
Eli Lilly made up 0.44% of Imprint Wealth's portfolio in Q2 2026, its #41 holding.
Imprint Wealth first reported a position in Eli Lilly in Q1 2023 and has held it in 9 quarters since.
Imprint Wealth's Eli Lilly position peaked at $3.25M in Q1 2024.
4,624 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Imprint Wealth's 13F filing for Q2 2026, filed 14 Aug 2026.